OA29 When IL-1 Inhibition is Just the Beginning: The Escalating Ladder of Refractory MAS.

Adult-onset chronic nonbacterial osteitis mimicking refractory axial psoriatic arthritis: successful treatment with combined IL-1/IL-17 inhibition: a case report and brief literature review
Alican Karakoc, Andreas Wirsching, Laura Bucci +4
EULAR Rheumatology Open23 Oct 2026Peer-reviewedCC BYFull textGeneral medicineDOAJEurope PMCEurope PMCPMC
RAF-independent MEK mutations drive refractory histiocytic neoplasms but respond to ERK inhibition
Eli L. Diamond, Jean-Francois Emile, Takeshi Fujino +42
Cancer Cell4 Nov 2026Peer-reviewedCC BY9 citedPhysiologyHAL
De-escalating Therapy in Obstructive Sleep Apnoea After Glucagon-Like Peptide-1 Receptor Agonist-Induced Weight Loss: A Narrative Review
Wares Jalil
Cureus19 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
The Escalating Cost of Disinvestment in the Health of Transgender Youths—From Research Retrenchment to the Criminalization of Care
Diana M. Tordoff, Alic G. Shook, Shelby Chestnut
JAMA Network Open30 Oct 2026Peer-reviewedCC BY 4.0General medicineCrossref
Beginning Kidney Replacement Therapy Before or After Liver Transplantation: Does the Timing of Dialysis Matter? A Cohort Study.
Patricia Faria Scherer, Adriano Luiz Ammirati, Bento Fortunato Cardoso Dos Santos +9
Journal of transplantation19 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeX

@article{anon2026oa29,
  title = {{OA29 When IL-1 Inhibition is Just the Beginning: The Escalating Ladder of Refractory MAS.}},
  journal = {Rheumatology advances in practice},
  year = {2026},
  month = nov,
  url = {https://europepmc.org/article/PMC/PMC13728631},
  note = {CC BY},
}

RIS

TY  - JOUR
TI  - OA29 When IL-1 Inhibition is Just the Beginning: The Escalating Ladder of Refractory MAS.
PY  - 2026
DA  - 2026/11/01
JO  - Rheumatology advances in practice
UR  - https://europepmc.org/article/PMC/PMC13728631
SN  - 2514-1775
ER  -

Related

Cite